Canadian Start-Ups continue to change the game within the Big Pharma industry. Having a significant research arm in Canada, BlueRock Therapeutics was recently sold to Germany’s Bayer for a $1 billion valuation. This
Alberta Innovates has proudly announced the Exploring Cannabis-Based Medicines and Tools (mCannabis) Program on December 9, 2019. The said program aims to provide new opportunity for stakeholders
The pharmaceutical industry has experienced an abundance of change and adaptation as of late due to recent advancements and technological growth. The capabilities of current
The Life Sciences–Biotech industry is one of the fastest-growing industries in Canada. With lots of room for experimentation and advancement, it is also a large contributor to
Regarding the recent legalization of cannabis in Canada, the country has become somewhat of a test patient in which the rest of the world is
With regards to the recent legalization of cannabis in Canada, people nationwide are now looking to establish themselves in the booming industry. Legal cannabis sales
Throughout the 21st century, we have seen the most rapid growth in technological advancements ever experienced. Society is consistently trying to find improvements in the
On October 7, 2018, the Federal government legalized the usage of cannabis and permitted private sales of cannabis products. For an industry that has long
BCIP is a permanent, competitive first purchase program offered by the Canadian government to allow small businesses in Canada to test and pre-sell technologies to
Creating a new drug, up to and including Phase III trials, to more effectively and safely reduce the risk of a stroke, is a qualifying
